{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T20:57:45Z","timestamp":1773781065776,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"29","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.vaccine.2013.04.057","type":"journal-article","created":{"date-parts":[[2013,5,10]],"date-time":"2013-05-10T03:12:27Z","timestamp":1368155547000},"page":"3000-3008","source":"Crossref","is-referenced-by-count":17,"title":["Immunogenicity of sequences around HIV-1 protease cleavage sites: Potential targets and population coverage analysis for a HIV vaccine targeting protease cleavage sites"],"prefix":"10.1016","volume":"31","author":[{"given":"Ma","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rupert","family":"Capina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Daniuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeff","family":"Tuff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harold","family":"Peters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makubo","family":"Kimani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Wachihi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Kimani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terry Blake","family":"Ball","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis A.","family":"Plummer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.04.057_bib0005","series-title":"UNAIDS","year":"2013"},{"issue":"6","key":"10.1016\/j.vaccine.2013.04.057_bib0010","first-page":"731","article-title":"AIDSVAX fails to prove efficacious in large-scale trial","volume":"2","year":"2003","journal-title":"Expert Rev Vaccines"},{"issue":"7161","key":"10.1016\/j.vaccine.2013.04.057_bib0015","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/449390c","article-title":"HIV vaccine failure prompts Merck to halt trial","volume":"449","year":"2007","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.vaccine.2013.04.057_bib0020","first-page":"20","article-title":"Therapeutic vaccine trial shows no benefit","volume":"11","year":"2007","journal-title":"IAVI Rep"},{"issue":"6153","key":"10.1016\/j.vaccine.2013.04.057_bib0025","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/331280a0","article-title":"Characterization of ribosomal frameshifting in HIV-1 gag-pol expression","volume":"331","author":"Jacks","year":"1988","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.vaccine.2013.04.057_bib0030","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1128\/JVI.67.7.4050-4055.1993","article-title":"Partial inhibition of the human immunodeficiency virus type 1 protease results in aberrant virus assembly and the formation of noninfectious particles","volume":"67","author":"Kaplan","year":"1993","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2013.04.057_bib0035","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1073\/pnas.86.3.807","article-title":"Activity of purified biosynthetic proteinase of human immunodeficiency virus on natural substrates and synthetic peptides","volume":"86","author":"Krausslich","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2013.04.057_bib0040","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S1054-3589(07)55008-8","article-title":"HIV-1 protease: structure, dynamics, and inhibition","volume":"55","author":"Louis","year":"2007","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.vaccine.2013.04.057_bib0045","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1146\/annurev.biophys.27.1.249","article-title":"Inhibitors of HIV-1 protease: a major success of structure-assisted drug design","volume":"27","author":"Wlodawer","year":"1998","journal-title":"Annu Rev Biophys Biomol Struct"},{"issue":"9","key":"10.1016\/j.vaccine.2013.04.057_bib0050","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1001\/archinte.1997.00440300037003","article-title":"Human immunodeficiency virus type 1 protease inhibitors","volume":"157","author":"McDonald","year":"1997","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.vaccine.2013.04.057_bib0055","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/QAD.0b013e328011e691","article-title":"HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance","volume":"21","author":"Shafer","year":"2007","journal-title":"AIDS"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2013.04.057_bib0060","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.drudis.2008.02.003","article-title":"Recent progress in antiretrovirals\u2014lessons from resistance","volume":"13","author":"Adamson","year":"2008","journal-title":"Drug Discov Today"},{"issue":"9","key":"10.1016\/j.vaccine.2013.04.057_bib0065","doi-asserted-by":"crossref","first-page":"6662","DOI":"10.1128\/JVI.71.9.6662-6670.1997","article-title":"Drug resistance during indinavir therapy is caused by mutations in the protease gene and in its Gag substrate cleavage sites","volume":"71","author":"Zhang","year":"1997","journal-title":"J Virol"},{"issue":"10","key":"10.1016\/j.vaccine.2013.04.057_bib0070","doi-asserted-by":"crossref","first-page":"4884","DOI":"10.1128\/JVI.02659-08","article-title":"Impact of human immunodeficiency virus type 1 resistance to protease inhibitors on evolution of resistance to the maturation inhibitor bevirimat (PA-457)","volume":"83","author":"Adamson","year":"2009","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2013.04.057_bib0075","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1128\/JVI.01926-10","article-title":"HIV-1 maturation inhibitor bevirimat stabilizes the immature Gag lattice","volume":"85","author":"Keller","year":"2010","journal-title":"J Virol"},{"issue":"8","key":"10.1016\/j.vaccine.2013.04.057_bib0080","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1517\/14728220903039714","article-title":"Virus maturation as a new HIV-1 therapeutic target","volume":"13","author":"Adamson","year":"2009","journal-title":"Expert Opin Ther Targets"},{"issue":"34","key":"10.1016\/j.vaccine.2013.04.057_bib0085","doi-asserted-by":"crossref","first-page":"17905","DOI":"10.1016\/S0021-9258(19)81300-5","article-title":"Synthetic peptides as substrates and inhibitors of human immune deficiency virus-1 protease","volume":"263","author":"Billich","year":"1988","journal-title":"J Biol Chem"},{"issue":"43","key":"10.1016\/j.vaccine.2013.04.057_bib0090","doi-asserted-by":"crossref","first-page":"29692","DOI":"10.1074\/jbc.M109.027144","article-title":"HIV-1 Gag processing intermediates trans-dominantly interfere with HIV-1 infectivity","volume":"284","author":"Muller","year":"2009","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.vaccine.2013.04.057_bib0095","doi-asserted-by":"crossref","first-page":"8017","DOI":"10.1128\/JVI.68.12.8017-8027.1994","article-title":"The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions","volume":"68","author":"Pettit","year":"1994","journal-title":"J Virol"},{"issue":"16","key":"10.1016\/j.vaccine.2013.04.057_bib0100","doi-asserted-by":"crossref","first-page":"8477","DOI":"10.1128\/JVI.78.16.8477-8485.2004","article-title":"Initial cleavage of the human immunodeficiency virus type 1 GagPol precursor by its activated protease occurs by an intramolecular mechanism","volume":"78","author":"Pettit","year":"2004","journal-title":"J Virol"},{"issue":"16","key":"10.1016\/j.vaccine.2013.04.057_bib0105","doi-asserted-by":"crossref","first-page":"10601","DOI":"10.1128\/JVI.79.16.10601-10607.2005","article-title":"Ordered processing of the human immunodeficiency virus type 1 GagPol precursor is influenced by the context of the embedded viral protease","volume":"79","author":"Pettit","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2013.04.057_bib0110","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1742-4690-2-66","article-title":"Processing sites in the human immunodeficiency virus type 1 (HIV-1) Gag-Pro-Pol precursor are cleaved by the viral protease at different rates","volume":"2","author":"Pettit","year":"2005","journal-title":"Retrovirology"},{"issue":"20","key":"10.1016\/j.vaccine.2013.04.057_bib0115","doi-asserted-by":"crossref","first-page":"10226","DOI":"10.1128\/JVI.76.20.10226-10233.2002","article-title":"Replacement of the P1 amino acid of human immunodeficiency virus type 1 Gag processing sites can inhibit or enhance the rate of cleavage by the viral protease","volume":"76","author":"Pettit","year":"2002","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2013.04.057_bib0120","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1128\/JVI.72.4.2846-2854.1998","article-title":"Sequential steps in human immunodeficiency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites","volume":"72","author":"Wiegers","year":"1998","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2013.04.057_bib0125","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11904-009-0035-7","article-title":"Use of nonhuman primate models to develop mucosal AIDS vaccines","volume":"7","author":"Genesca","year":"2010","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"7","key":"10.1016\/j.vaccine.2013.04.057_bib0130","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1056\/NEJM198602133140704","article-title":"AIDS virus infection in Nairobi prostitutes. Spread of the epidemic to East Africa","volume":"314","author":"Kreiss","year":"1986","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2013.04.057_bib0135","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00002030-199002000-00007","article-title":"HIV infection among lower socioeconomic strata prostitutes in Nairobi","volume":"4","author":"Simonsen","year":"1990","journal-title":"AIDS (London, England)"},{"issue":"11","key":"10.1016\/j.vaccine.2013.04.057_bib0140","doi-asserted-by":"crossref","first-page":"7467","DOI":"10.1128\/JVI.68.11.7467-7481.1994","article-title":"Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences","volume":"68","author":"Korber","year":"1994","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2013.04.057_bib0145","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.tim.2012.11.006","article-title":"HIV Gag polyprotein: processing and early viral particle assembly","volume":"21","author":"Bell","year":"2013","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2013.04.057_bib0150","series-title":"Identification of Human MHC Class I Binding Peptides using the iTOPIA\u2122-Epitope Discovery System","author":"Markus Wulf PHaPT","year":"2009"},{"issue":"8","key":"10.1016\/j.vaccine.2013.04.057_bib0155","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/intimm\/dxn063","article-title":"Identification and functional validation of MHC class I epitopes in the tumor-associated antigen 5T4","volume":"20","author":"Shingler","year":"2008","journal-title":"Int Immunol"},{"key":"10.1016\/j.vaccine.2013.04.057_bib0160","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/978-1-59745-450-6_26","article-title":"Identification of human MHC class I binding peptides using the iTOPIA-Epitope Discovery System","volume":"524","author":"Wulf","year":"2009","journal-title":"Methods Mol Biol"},{"issue":"2","key":"10.1016\/j.vaccine.2013.04.057_bib0165","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.05721-11","article-title":"For protection from HIV-1 infection, more might not be better: a systematic analysis of HIV Gag epitopes of two alleles associated with different outcomes of HIV-1 infection","volume":"86","author":"Luo","year":"2012","journal-title":"J Virol"},{"issue":"1-2","key":"10.1016\/j.vaccine.2013.04.057_bib0170","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jim.2009.11.002","article-title":"Identification and characterization of HLA-A*0301 epitopes in HIV-1 gag proteins using a novel approach","volume":"352","author":"Semeniuk","year":"2010","journal-title":"J Immunol Methods"},{"issue":"7","key":"10.1016\/j.vaccine.2013.04.057_bib0175","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/QAD.0b013e32832995e0","article-title":"Multiple T-cell epitopes overlap positively-selected residues in the p1 spacer protein of HIV-1 gag","volume":"23","author":"Semeniuk","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.vaccine.2013.04.057_bib0180","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1471-2105-7-153","article-title":"Predicting population coverage of T-cell epitope-based diagnostics and vaccines","volume":"7","author":"Bui","year":"2006","journal-title":"BMC Bioinformatics"},{"issue":"5","key":"10.1016\/j.vaccine.2013.04.057_bib0185","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1034\/j.1399-0039.2003.00112.x","article-title":"Sensitive quantitative predictions of peptide-MHC binding by a \u2018Query by Committee\u2019 artificial neural network approach","volume":"62","author":"Buus","year":"2003","journal-title":"Tissue Antigens"},{"issue":"5","key":"10.1016\/j.vaccine.2013.04.057_bib0190","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1110\/ps.0239403","article-title":"Reliable prediction of T-cell epitopes using neural networks with novel sequence representations","volume":"12","author":"Nielsen","year":"2003","journal-title":"Protein Sci"},{"issue":"11","key":"10.1016\/j.vaccine.2013.04.057_bib0195","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/bioinformatics\/btn128","article-title":"Accurate approximation method for prediction of class I MHC affinities for peptides of length 8, 10 and 11 using prediction tools trained on 9mers","volume":"24","author":"Lundegaard","year":"2008","journal-title":"Bioinformatics"},{"issue":"17","key":"10.1016\/j.vaccine.2013.04.057_bib0200","doi-asserted-by":"crossref","first-page":"9422","DOI":"10.1128\/JVI.77.17.9422-9430.2003","article-title":"Variability at human immunodeficiency virus type 1 subtype C protease cleavage sites: an indication of viral fitness?","volume":"77","author":"de Oliveira","year":"2003","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2013.04.057_bib0205","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/nm0310-268","article-title":"HIV vaccines: mosaic approach to virus diversity","volume":"16","author":"Corey","year":"2010","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.vaccine.2013.04.057_bib0210","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nm.2089","article-title":"Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys","volume":"16","author":"Barouch","year":"2010","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.vaccine.2013.04.057_bib0215","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1371\/journal.ppat.0030157","article-title":"HIV-1 group M conserved elements vaccine","volume":"3","author":"Rolland","year":"2007","journal-title":"PLoS Pathog"},{"issue":"10","key":"10.1016\/j.vaccine.2013.04.057_bib0220","doi-asserted-by":"crossref","first-page":"e984","DOI":"10.1371\/journal.pone.0000984","article-title":"Design and pre-clinical evaluation of a universal HIV-1 vaccine","volume":"2","author":"Letourneau","year":"2007","journal-title":"PLoS ONE"},{"issue":"21","key":"10.1016\/j.vaccine.2013.04.057_bib0225","doi-asserted-by":"crossref","first-page":"7552","DOI":"10.1073\/pnas.0802203105","article-title":"Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection","volume":"105","author":"Keele","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"10.1016\/j.vaccine.2013.04.057_bib0230","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1128\/JVI.02132-08","article-title":"Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants","volume":"83","author":"Abrahams","year":"2009","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2013.04.057_bib0235","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.1128\/JVI.00077-10","article-title":"Wide variation in the multiplicity of HIV-1 infection among injection drug users","volume":"84","author":"Bar","year":"2010","journal-title":"J Virol"},{"issue":"8","key":"10.1016\/j.vaccine.2013.04.057_bib0240","doi-asserted-by":"crossref","first-page":"e12303","DOI":"10.1371\/journal.pone.0012303","article-title":"Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing","volume":"5","author":"Fischer","year":"2010","journal-title":"PLoS ONE"},{"issue":"19","key":"10.1016\/j.vaccine.2013.04.057_bib0245","doi-asserted-by":"crossref","first-page":"10406","DOI":"10.1128\/JVI.01155-10","article-title":"Low-dose mucosal simian immunodeficiency virus infection restricts early replication kinetics and transmitted virus variants in rhesus monkeys","volume":"84","author":"Liu","year":"2010","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2013.04.057_bib0250","doi-asserted-by":"crossref","first-page":"e1000890","DOI":"10.1371\/journal.ppat.1000890","article-title":"High multiplicity infection by HIV-1 in men who have sex with men","volume":"6","author":"Li","year":"2010","journal-title":"PLoS Pathog"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13005264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13005264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T17:08:01Z","timestamp":1645031281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13005264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":50,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0264410X13005264"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.04.057","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}